-
Stephan Moll, MD writes (last updated: Sept 9th, 2020)… Background: Hospitalized patients with COVID-19 are at increased risk for thrombosis – DVT, PE, and may be pulmonary micro-vascular thrombosis that possibly contributes to respiratory failure; arterial events appear to occur less commonly. Scientific/clinical data on prevalence of thrombosis, best prevention, and optimal therapy are limited.
-
Summary A recent summary of all published good quality trials (randomized, placebo-controlled) shows that taking vitamin E supplements slightly increases a person’s risk for bleeding into the brain (reference 1). My conclusions: (a) I caution against the use of daily vitamin E supplementation, and (b) I advise against the use of vitamin E in patients who are already
-
Background and Summary Patients on warfarin can test their own INR (International Normalized Ratio) at home with small, handheld INR monitors, similar to diabetics checking their own blood sugar. A very large, well conducted study published on Oct 21, 2010 in the New England Journal of Medicine (ref 1) shows that patients can safely and
-
Summary The new oral “blood thinner” Pradaxa® (=Dabigatran) was approved by the FDA on October 20th, 2010 (ref 1 and 2). This is huge news! This is the first oral blood thinner alternative to warfarin (=Coumadin®, Jantoven®). At this point, Pradaxa® is only FDA approved for use in patients with irregular heart beat (= atrial
A Clearinghouse for Information about Blood Clots (DVT/)PE) and Clotting Disorders (thrombophilia) provided as a public service by the University of North Carolina Blood Research Center
Clot Connect 